The effect of a D2-specific dopamine agonist (Pramipexole) on response time in early Parkinson's disease patients

Psychobiology

Volumn 25, Issue 4, 1997, Pages 321-326

  Willingham, Daniel B ^a   Bennett, James P ^a   Greenberg, Nevin J ^a   Rost Ruffner, Elke ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PLACEBO; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; BODY MOVEMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; PARKINSON DISEASE; REACTION TIME; TASK PERFORMANCE;

EID: 0031425296     PISSN: 08896313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BARONE, P., & JOSEPH, J. P. (1989). Role of the dorsolateral prefrontal cortex in organizing visually guided behavior. Brain, Behavior & Evolution, 33, 132-135.
2. BENNETT, J. P., JR., LANDOW, E. R., & SCHUH, L. A. (1993). Suppression of dyskinesias in advanced Parkinson's disease: II. Increasing daily clozapine doses suppress dyskinesias and improve Parkinsonism symptoms. Neurology, 43, 1551-1555.
3. BROWN, V. J., SCHWARTZ, U., BOWMAN, E. M., FUHR, P., ROBINSON, D. L., & HALLETT, M. (1993). Dopamine dependent reaction time deficits in patients with Parkinson's disease are task specific. Neuropsychologia, 31, 459-469.
4. CALON, F., GOULET, M., BLANCHET, P. J., MARTEL, J. C., PEIRCEY, M. F., BEDARD, P. J., & DIPAOLO, T. (1995). Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABA receptors in the striatopallidal complex. Brain Research, 680, 43-52.
5. CARLSON, J. H., BERGSTROM, D. A., & WALTER, J. R. (1987). Stimulation of both D1 and D2 receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study. Brain Research, 400, 205-218.
6. ENGBER, T. M., SUSEL, Z., JUNCOS, J. L., & CHASE, T. N. (1988). Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists. European Journal of Pharmacology, 168, 291-298.
7. GERFEN, C. R., ENGBER, T. M., MAHAN, L. C., SUSEL, Z., CHASE, T. N., MONSMA, F. J., & SIBLEY, D. R. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 1429-1432.
8. GOLDMAN-RAKIC, P. S., LIDOW, M. S., & GALLAGER, D. W. (1990). Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. Journal of Neuroscience, 10, 2125-2138.
9. GROWDON, J. H., & CORKIN, S. (1986). Cognitive impairments in Parkinson's disease. In M. D. Yahr & K. J. Bergman (Eds.), Advances in neurology (Vol. 45, pp. 382-393). New York: Raven Press.
10. HOEHN, M. M., & YAHR, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427-442.
11. HUBBLE, J. P., KOLLER, W. C., CUTLER, N. R., SRAMEK, J. J., FRIEDMAN, J., GOETZ, C., RANHOSKY, A., KORTS, D., & ELVIN, A. (1995). Pramipexole in patients with early Parkinson's disease. Clinical Neuropharmacology, 18, 338-347.
12. JAHANSHAHI, M., BROWN, R. G., & MARSDEN, C. D. (1992). The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 55, 1168-1176.
13. MANN, S. E., THAU, R., & SCHILLER, P. H. (1988). Conditional task-related responses in monkey dorsomedial frontal cortex. Experimental Brain Research, 69, 460-468.
14. MOURADIAN, M. M., JUNCOS, J. L., GABBRINI, G., SCHLEGEL, J., BARTKO, J. J., & CHASE, T. N. (1988). Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part II. Annals of Neurology, 24, 372-378.
15. MURRAY, A. M., & WADDINGTON, J. L. (1990). The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: Behavioral indices. European Journal of Pharmacology, 186, 79-86.
16. OROSZ, D., & BENNETT, J. P., JR. (1992). Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of 1-dihydroxyphenylalanine in the "hemiparkinsonian" rat. Experimental Neurology, 115, 388-393.
17. PULLMAN, S. L., WATTS, R. L., JUNCOS, J. L., CHASE, T. N., & SANES, J. N. (1988). Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology, 38, 249-254.
18. ROUILLARD, C., BEDARD, P. J., & DIPAOLO, T. (1990). Behavioral and biochemical effect of chronic treatment of MPTP-monkeys with bromocriptine alone or in combination with SKF 38393. European Journal of Pharmacology, 185, 209-215.
19. STARKSTEIN, S. E., ESTEGUY, M., BERTHIER, M. L., GARCIA, H., & LEIGUARDA, R. (1989). Evoked potentials, reaction time, and cognitive performance in on and off phases of Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 52, 338-340.
20. VELASCO, F., & VELASCO, M. (1973). A quantitative evaluation of the effects of L-DOPA on Parkinson's disease. Neuropharmacology, 12, 89-99.
21. WALTERS, J. R., BERGSTROM, D. A., CARLSON, J. H., CHASE, T. N., & BRAUN, A. R. (1987). D1 receptor activation required for postsynaptic expression of D2 agonist effects. Science, 236, 719-722.